Diagnostic random bladder biopsies: Reflections from a population-based cohort of 538 patients

Scandinavian Journal of Urology and Nephrology

Volumn 44, Issue 1, 2010, Pages 11-19

  Thorstenson, Andreas ^a   Schumacher, Martin C ^a   Wiklund, N Peter ^a   Jonsson, Martin N ^a   Larsson, Per ^b   Wijkstrm, Hans ^c   Onelv, Erik ^b   Steineck, Gunnar ^b,d   De Verdier, Petra J ^a,b  

^a Department of Molecular Medicine and Surgery   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

^d SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Bladder cancer; Concomitant carcinoma in situ; Random bladder biopsy; Survival; Transitional cell carcinoma

Indexed keywords

BCG VACCINE;

ADULT; AGED; ARTICLE; BLADDER BIOPSY; BLADDER CARCINOMA; CANCER MORTALITY; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CARCINOMA IN SITU; CONTROLLED STUDY; CYSTECTOMY; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; TRANSITIONAL CELL CARCINOMA; UROLOGY;

AGED; AGED, 80 AND OVER; BIOPSY; CARCINOMA IN SITU; CARCINOMA, TRANSITIONAL CELL; COHORT STUDIES; FEMALE; HUMANS; MALE; NEOPLASM STAGING; NEOPLASMS, MULTIPLE PRIMARY; PROSPECTIVE STUDIES; URINARY BLADDER NEOPLASMS;

EID: 76749162310     PISSN: 00365599     EISSN: 16512065     Source Type: Journal    
DOI: 10.3109/00365590903419020     Document Type: Article

References (14)

1. Babjuk M, Oosterlinck W, Sylvester R, Kaasinen E, Bohle A, Palou-Redorta J. EAU guidelines on non-muscle-invasive urothelialcarcinomaofthebladder. EurUrol2008;54:303-314
2. van der Meijden A, Oosterlinck W, Brausi M, Kurth KH, Sylvester R, de Balincourt C. Significance of bladder biopsies in Ta, T1 bladder tumors: a report from the EORTC Genito- Urinary Tract Cancer Cooperative Group. EORTC-GU Group Superficial Bladder Committee. Eur Urol 1999;35:267-271
3. Shariat SF, Palapattu GS, Karakiewicz PI, Rogers CG, Vazina A, Bastian PJ, et al. Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ-confined TCC at radical cystectomy. Eur Urol 2007;51:152-160
4. Sylvester RJ, van der Meijden AP, Oosterlinck W, Witjes JA, Bouffioux C, Denis L, et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 2006;49:466-477
5. May F, Treiber U, Hartung R, Schwaibold H. Significance of random bladder biopsies in superficial bladder cancer. Eur Urol 2003;44:47-50.
6. Larsson P, Wijkstrom H, Thorstenson A, Adolfsson J, Norming U, Wiklund P, et al. A population-based study of 538 patients with newly detected urinary bladder neoplasms followedduring5years.ScandJUrolNephrol2003;37:195-201.
7. Bergkvist A, Ljungqvist A, Moberger G. Classification of bladder tumours based on the cellular pattern. Preliminary report of a clinical-pathological study of 300 cases with a minimum follow-up of eight years. Acta Chir Scand 1965;130:371-378
8. Carbin BE, Ekman P, Gustafson H, Christensen NJ, Sandstedt B, Silfversward C. Grading of human urothelial carcinoma based on nuclear atypia and mitotic frequency. I. Histological description. J Urol 1991;145:968-971
9. Reuter VE, Epstein JI, Amin MB, Mostofi FK. The "WHO/ ISUP Consensus Classification of Urothelial (Transitional Cell) Neoplasms": continued discussion. Hum Pathol 1999;30:879-880
10. Bohle A, Bock PR. Intravesical bacille Calmette-Guerin versus mitomycin C in superficial bladder cancer: formal meta-analysis of comparative studies on tumor progression. Urology 2004;63:682-687
11. Sylvester RJ, van der Meijden AP, Lamm DL. Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials. J Urol 2002;168:1964-1970
12. Stein JP, Penson DF. Invasive T1 bladder cancer: indications and rationale for radical cystectomy. BJU Int 2008;102:270-275
13. Gardmark T, Bladstrom A, Hellsten S, Malmstrom PU, Members of the Swedish National Bladder Cancer Registry. Analysis of clinical characteristics, management and survival of patients with Ta T1 bladder tumours in Sweden between 1997 and 2001. Scand J Urol Nephrol 2006;40:276-282
14. Kirkali Z, Chan T, Manoharan M, Algaba F, Busch C, Cheng L, et al. Bladder cancer: epidemiology, staging and grading, and diagnosis. Urology 2005;66:4-34.